146 related articles for article (PubMed ID: 38569127)
1. Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication.
Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Rosati E; Catania C; Ferlazzo E; Casciato S; Di Gennaro G; Pizzanelli C; Giuliano L; Viola V; Mostacci B; Pignatta P; Fortunato F; Pulitano P; Panzini C; Gambardella A; Atalar AÇ; Labate A; Operto FF; Giallonardo AT; Baykan BB; Beier CP; Di Bonaventura C;
Neurology; 2024 May; 102(9):e209222. PubMed ID: 38569127
[TBL] [Abstract][Full Text] [Related]
2. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
[TBL] [Abstract][Full Text] [Related]
3. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.
Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Catania C; Ferlazzo E; Pascarella A; Casciato S; Quarato P; Pizzanelli C; Pulitano P; Giuliano L; Viola V; Mostacci B; Fortunato F; Marini C; Di Gennaro G; Gambardella A; Labate A; Operto FF; Giallonardo AT; Baykan B; Beier CP; Di Bonaventura C;
JAMA Neurol; 2023 Nov; 80(11):1174-1181. PubMed ID: 37782485
[TBL] [Abstract][Full Text] [Related]
5. Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy.
Pipek LZ; Pipek HZ; Castro LHM
Sci Rep; 2022 Jul; 12(1):12350. PubMed ID: 35854146
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
[TBL] [Abstract][Full Text] [Related]
7. Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.
Cerulli Irelli E; Morano A; Cocchi E; Casciato S; Fanella M; Albini M; Avorio F; Basili LM; Fisco G; Barone FA; Mascia A; D'Aniello A; Manfredi M; Fattouch J; Quarato P; Giallonardo AT; Di Gennaro G; Di Bonaventura C
Epilepsia; 2020 Jan; 61(1):107-114. PubMed ID: 31828782
[TBL] [Abstract][Full Text] [Related]
8. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
[TBL] [Abstract][Full Text] [Related]
9. Epilepsy with generalized tonic-clonic seizures alone: Electroclinical features and prognostic patterns.
Cerulli Irelli E; Gesche J; Schlabitz S; Fortunato F; Catania C; Morano A; Labate A; Vorderwülbecke BJ; Gambardella A; Baykan B; Holtkamp M; Di Bonaventura C; Beier CP
Epilepsia; 2024 Jan; 65(1):84-94. PubMed ID: 37872695
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Valproate and Lamotrigine/Levetiracetam Use and Prognosis in Patients With Epilepsy and Heart Failure: A Danish Register-Based Study.
Liang D; Gardella E; Kragholm K; Polcwiartek C; Sessa M
J Card Fail; 2022 Apr; 28(4):630-638. PubMed ID: 34438055
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness analysis of three-drug combination therapies for refractory focal epilepsy.
Wu C; Wu H; Zhou Y; Liu X; Huang S; Zhu S
Neurotherapeutics; 2024 Apr; 21(3):e00345. PubMed ID: 38490875
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
13. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
14. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
Guo Y; Lin Z; Huang Y; Yu L
Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
[TBL] [Abstract][Full Text] [Related]
15. Predictors of successful valproate withdrawal in women with epilepsy.
Atalar AÇ; Şirin NG; Bebek N; Baykan B
Epilepsy Behav; 2021 Jun; 119():107980. PubMed ID: 33957390
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Neurology; 2023 Apr; 100(14):e1488-e1496. PubMed ID: 36754633
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Neurology; 2022 Sep; 99(10):e999-e1008. PubMed ID: 36219797
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
Ballvé A; Salas-Puig J; Quintana M; Campos D; Llauradó A; Raspall M; Fonseca E; Abraira L; Santamarina E; Toledo M
Acta Neurol Scand; 2021 Apr; 143(4):407-412. PubMed ID: 33452703
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
